49
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Impact of time of initiation of once-monthly paliperidone palmitate in hospitalized Asian patients with acute exacerbation of schizophrenia: a post hoc analysis from the PREVAIL study

, , , , , & show all
Pages 1107-1117 | Published online: 26 Apr 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Ning Ma, Lei Zhang, Wufang Zhang, Yingying He, Chong Ye & Xin Li. (2023) Long-Acting Injectable Antipsychotic Treatment for Schizophrenia in Asian Population: A Scoping Review. Neuropsychiatric Disease and Treatment 19, pages 1987-2006.
Read now
Maju Mathews, Srihari Gopal, Isaac Nuamah, Ludger Hargarter, Adam J Savitz, Edward Kim, Wilson Tan, Bernardo Soares & Christoph U Correll. (2019) Clinical relevance of paliperidone palmitate 3-monthly in treating schizophrenia. Neuropsychiatric Disease and Treatment 15, pages 1365-1379.
Read now

Articles from other publishers (1)

Chun Ting Chan, Swapna Verma, Mythily Subramaniam, Edimansyah Abdin & Jenny Tay. (2023) Effectiveness of Paliperidone Palmitate in Reducing Acute Psychiatric Service Use for Patients Suffering from Psychosis—A Retrospective Mirror-Image Study. International Journal of Environmental Research and Public Health 20:4, pages 3403.
Crossref